Moreover, tirzepatide outperformed semaglutide when it came to weight loss, with tirzepatide doses of 15 mg, 10 mg, and 5 mg delivering notable reductions in body weight (-10.96 Kg, -8.75 Kg, and -6.16 Kg, respectively) compared to semaglutide (-5.24 Kg, -4.44 Kg, and -2.72 Kg for semaglutide at 2.0, 1.0, and 0.5 mg, respectively)
DPP-4 inhibitors like sitagliptin/Januvia) that indirectly boost GLP-1 by stopping its degradation, but those are a different class
Medical Care 2017, 55: 528-534
Injectable GHK-Cu delivers the compound systemically, affecting collagen synthesis throughout the body including in deep dermal layers, connective tissue, joint structures, and internal organs